We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

103 hedge funds and large institutions have $259M invested in GenMark Diagnostics, Inc in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 29

3% less funds holding

Funds holding: 106103 (-3)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

35% less capital invested

Capital invested by funds: $400M → $259M (-$142M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $59K

Holders
103
Holders Change
-3
Holders Change %
-2.83%
% of All Funds
2.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
34
Reduced
29
Closed
15
Calls
Puts
$59K
Net Calls
-$59K
Net Calls Change
-$59K
Name Holding Trade Value Shares
Change
Change in
Stake
WI
51
WrapManager Inc
California
$280K +$47.8K +9,180 +19%
AllianceBernstein
52
AllianceBernstein
Tennessee
$271K
California Public Employees Retirement System
53
California Public Employees Retirement System
California
$236K
ONB
54
Old National Bancorp
Indiana
$236K +$14.1K +2,700 +6%
Baird Financial Group
55
Baird Financial Group
Wisconsin
$230K
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$226K
Wells Fargo
57
Wells Fargo
California
$224K +$83.4K +16,009 +53%
PP
58
PDT Partners
New York
$221K +$53.5K +10,279 +29%
Millennium Management
59
Millennium Management
New York
$214K -$3.06M -587,496 -93%
LOAMU
60
Lombard Odier Asset Management (USA)
New York
$209K +$41.2K +7,920 +23%
Manulife (Manufacturers Life Insurance)
61
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$166K -$11.6K -2,236 -6%
AIG
62
American International Group
New York
$166K -$1.36K -262 -0.8%
MFIM
63
Mesirow Financial Investment Management
Illinois
$160K
CS
64
Credit Suisse
Switzerland
$156K -$854 -164 -0.5%
State Board of Administration of Florida Retirement System
65
State Board of Administration of Florida Retirement System
Florida
$129K
MIM
66
MetLife Investment Management
New Jersey
$128K
JG
67
Jefferies Group
New York
$121K +$53.4K +10,258 +70%
Invesco
68
Invesco
Georgia
$120K -$26K -4,989 -17%
UBS Group
69
UBS Group
Switzerland
$116K +$34.6K +6,636 +38%
QSS
70
Quantitative Systematic Strategies
Florida
$116K +$125K +23,947 New
PCMI
71
Paradigm Capital Management Inc
New York
$96K
VOYA Investment Management
72
VOYA Investment Management
Georgia
$96K
MLICM
73
Metropolitan Life Insurance Company (MetLife)
New York
$90.1K
CCIA
74
Campbell & Co Investment Adviser
Maryland
$84K +$81.2K +15,599 New
PP
75
Paloma Partners
Connecticut
$80K +$85.9K +16,500 New

GNMK Hedge Fund Activity: Q4 2018 in Review

103 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q4 2018, worth a combined $259M — down 35% from $400M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of GNMK and 12 opened new positions — a net loss of 3 holders — while 29 trimmed existing stakes and 34 added.

The largest buyer was Cadian Capital Management, adding an estimated $6.13M. The largest seller was Putnam Investments, exiting entirely with an estimated $25.7M sold.

  • 103 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q4 2018, down from 106 in Q3 2018.
  • Funds reported $259M of GenMark Diagnostics, Inc stock for Q4 2018, down 35% quarter-over-quarter.
  • 12 funds opened new GenMark Diagnostics, Inc positions in Q4 2018 and 15 closed out, a net change of -3 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q4 2018 was Cadian Capital Management, an estimated $6.13M added.
  • The largest GenMark Diagnostics, Inc seller in Q4 2018 was Putnam Investments, an estimated $25.7M sold.

Based on aggregated 13F filings for Q4 2018.